| Primary |
| Product Used For Unknown Indication |
18.2% |
| Abdominal Pain Upper |
9.1% |
| Anxiety |
9.1% |
| Back Pain |
9.1% |
| Constipation |
9.1% |
| Depressed Mood |
9.1% |
| Extrapyramidal Disorder |
9.1% |
| Insomnia |
9.1% |
| Salivary Hypersecretion |
9.1% |
| Schizophrenia |
9.1% |
|
| Toxicity To Various Agents |
100.0% |
|
| Secondary |
| Schizophrenia |
26.0% |
| Depressed Mood |
17.0% |
| Epilepsy |
12.0% |
| Product Used For Unknown Indication |
12.0% |
| Schizoaffective Disorder |
8.0% |
| Drooling |
6.0% |
| Adverse Drug Reaction |
4.0% |
| Anxiety |
3.0% |
| Salivary Hypersecretion |
3.0% |
| Depression |
2.0% |
| Schizophrenia, Paranoid Type |
2.0% |
| Sedation |
2.0% |
| Bipolar I Disorder |
1.0% |
| Extrapyramidal Disorder |
1.0% |
| Low Mood |
1.0% |
|
| White Blood Cell Count Increased |
27.3% |
| Anxiety |
13.6% |
| Therapy Responder |
13.6% |
| Haemoglobin Decreased |
9.1% |
| Incorrect Dose Administered |
9.1% |
| Tachycardia |
9.1% |
| Cardiac Failure |
4.5% |
| Intentional Drug Misuse |
4.5% |
| Therapeutic Response Decreased |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
|
| Concomitant |
| Schizophrenia |
29.3% |
| Salivary Hypersecretion |
16.2% |
| Product Used For Unknown Indication |
15.5% |
| Depression |
5.6% |
| Psychotic Disorder |
5.0% |
| Anxiety |
4.3% |
| Schizophrenia, Paranoid Type |
3.7% |
| Extrapyramidal Disorder |
2.2% |
| Sleep Disorder |
1.9% |
| Constipation |
1.8% |
| Affective Disorder |
1.7% |
| General Physical Condition Abnormal |
1.7% |
| Dementia |
1.6% |
| Hypertension |
1.6% |
| Mental Disorder |
1.6% |
| Pain |
1.4% |
| Diabetes Mellitus |
1.3% |
| Irritable Bowel Syndrome |
1.3% |
| Agitation |
1.2% |
| Blood Cholesterol Increased |
1.2% |
|
| White Blood Cell Count Increased |
20.9% |
| White Blood Cell Count Decreased |
9.1% |
| Neutropenia |
6.4% |
| Neutrophil Count Increased |
6.4% |
| Death |
4.5% |
| Lower Respiratory Tract Infection |
4.5% |
| Lymphocyte Count Increased |
4.5% |
| Neuroleptic Malignant Syndrome |
4.5% |
| Viral Infection |
4.5% |
| Eosinophil Count Increased |
3.6% |
| Haemoglobin Decreased |
3.6% |
| Neutrophil Count Decreased |
3.6% |
| Platelet Count Decreased |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Anaemia |
2.7% |
| Blood Alkaline Phosphatase Increased |
2.7% |
| Blood Creatine Phosphokinase Increased |
2.7% |
| Fatigue |
2.7% |
| Hypothyroidism |
2.7% |
| Lung Neoplasm Malignant |
2.7% |
|
